291 related articles for article (PubMed ID: 6389812)
1. Comparison between bone marrow transplantation and antithymocyte globulin in treatment of young patients with severe aplastic anemia.
Bayever E; Champlin R; Ho W; Lenarsky C; Storch S; Ladisch S; Gale RP; Feig SA
J Pediatr; 1984 Dec; 105(6):920-5. PubMed ID: 6389812
[TBL] [Abstract][Full Text] [Related]
2. Beneficial Role of Low-Dose Antithymocyte Globulin in Unrelated Stem Cell Transplantation for Adult Patients with Acquired Severe Aplastic Anemia: Reduction of Graft-versus-Host Disease and Improvement of Graft-versus-Host Disease-Free, Failure-Free Survival Rate.
Park SS; Kwak DH; Jeon YW; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Min WS; Lee JW
Biol Blood Marrow Transplant; 2017 Sep; 23(9):1498-1508. PubMed ID: 28554856
[TBL] [Abstract][Full Text] [Related]
3. Marrow transplants from unrelated donors for patients with aplastic anemia: minimum effective dose of total body irradiation.
Deeg HJ; Amylon ID; Harris RE; Collins R; Beatty PG; Feig S; Ramsay N; Territo M; Khan SP; Pamphilon D; Leis JF; Burdach S; Anasetti C; Hackman R; Storer B; Mueller B
Biol Blood Marrow Transplant; 2001; 7(4):208-15. PubMed ID: 11349807
[TBL] [Abstract][Full Text] [Related]
4. Treatment of adults with severe aplastic anemia: primary therapy with antithymocyte globulin (ATG) and rescue of ATG failures with bone marrow transplantation.
Crump M; Larratt LM; Maki E; Curtis JE; Minden MD; Meharchand JM; Lipton JH; Messner HA
Am J Med; 1992 Jun; 92(6):596-602. PubMed ID: 1605140
[TBL] [Abstract][Full Text] [Related]
5. Effect of antithymocyte globulin source on outcomes of bone marrow transplantation for severe aplastic anemia.
Kekre N; Zhang Y; Zhang MJ; Carreras J; Ahmed P; Anderlini P; Atta EH; Ayas M; Boelens JJ; Bonfim C; Deeg HJ; Kapoor N; Lee JW; Nakamura R; Pulsipher MA; Eapen M; Antin JH
Haematologica; 2017 Jul; 102(7):1291-1298. PubMed ID: 28341733
[TBL] [Abstract][Full Text] [Related]
6. Different outcomes between cyclophosphamide plus horse or rabbit antithymocyte globulin for HLA-identical sibling bone marrow transplant in severe aplastic anemia.
Atta EH; de Sousa AM; Schirmer MR; Bouzas LF; Nucci M; Abdelhay E
Biol Blood Marrow Transplant; 2012 Dec; 18(12):1876-82. PubMed ID: 22796534
[TBL] [Abstract][Full Text] [Related]
7. Effect of Antithymocyte Globulin Source on Outcomes of HLA-Matched Sibling Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Severe Aplastic Anemia.
Chen X; Wei J; Huang Y; He Y; Yang D; Zhang R; Jiang E; Ma Q; Zhai W; Yao J; Zhang G; Feng S; Han M
Biol Blood Marrow Transplant; 2018 Jan; 24(1):86-90. PubMed ID: 29032265
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow transplantation for patients with acquired severe aplastic anemia using cyclophosphamide and antithymocyte globulin: the experience from a single center.
Abdelkefi A; Ben Othman T; Ladeb S; Torjman L; Hsaïri M; Ben Abdeladhim A
Hematol J; 2003; 4(3):208-13. PubMed ID: 12764353
[TBL] [Abstract][Full Text] [Related]
9. Conditioning with cyclophosphamide/antithymocyte globulin for allogeneic bone marrow transplantation from HLA-matched siblings in children with severe aplastic anemia.
Azuma E; Kojima S; Kato K; Matsuyama T; Yamada Y; Kondo N; Sawada H; Hanada M; Shibata T; Tabata N; Watanabe M; Shimono Y; Deguchi T; Umemoto M; Higashikawa M; Kawasaki H; Komada Y; Sakurai M
Bone Marrow Transplant; 1997 Jun; 19(11):1085-7. PubMed ID: 9193750
[TBL] [Abstract][Full Text] [Related]
10. Second marrow transplants in patients with aplastic anemia rejecting the first graft: use of a conditioning regimen including cyclophosphamide and antithymocyte globulin.
Storb R; Weiden PL; Sullivan KM; Appelbaum FR; Beatty P; Buckner CD; Clift RA; Doney KC; Hansen J; Martin PJ
Blood; 1987 Jul; 70(1):116-21. PubMed ID: 3297199
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow versus peripheral blood as the stem cell source for sibling transplants in acquired aplastic anemia: survival advantage for bone marrow in all age groups.
Bacigalupo A; Socié G; Schrezenmeier H; Tichelli A; Locasciulli A; Fuehrer M; Risitano AM; Dufour C; Passweg JR; Oneto R; Aljurf M; Flynn C; Mialou V; Hamladji RM; Marsh JC;
Haematologica; 2012 Aug; 97(8):1142-8. PubMed ID: 22315497
[TBL] [Abstract][Full Text] [Related]
12. Aplastic anemia treated by allogeneic bone marrow transplantation: a report on 49 new cases from Seattle.
Storb R; Thomas ED; Weiden PL; Buckner CD; Clift RA; Fefer A; Fernando LP; Giblett ER; Goodell BW; Johnson FL; Lerner KG; Neiman PE; Sanders JE
Blood; 1976 Dec; 48(6):817-41. PubMed ID: 11859
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcome of aplastic anemia in adults treated with antithymocyte globulin: comparison with bone marrow transplantation.
Paquette RL; Tebyani N; Frane M; Ireland P; Ho WG; Champlin RE; Nimer SD
Blood; 1995 Jan; 85(1):283-90. PubMed ID: 7803802
[TBL] [Abstract][Full Text] [Related]
14. Treatment of severe aplastic anemia: comparison of bone marrow transplantation to immunotherapy.
Tzeng CH; Chen PM; Chuang MW; Liu JH; Hsieh RK; Liu CJ; Fan S; Chen KY; Yung CH; Wang SY
Zhonghua Yi Xue Za Zhi (Taipei); 1989 Jan; 43(1):21-8. PubMed ID: 2670137
[TBL] [Abstract][Full Text] [Related]
15. Treatment of severe aplastic anemia using antithymocyte globulin with or without an infusion of HLA haploidentical marrow.
Doney KC; Weiden PL; Buckner CD; Storb R; Thomas ED
Exp Hematol; 1981 Sep; 9(8):829-34. PubMed ID: 7035206
[TBL] [Abstract][Full Text] [Related]
16. Retrospective study of alemtuzumab vs ATG-based conditioning without irradiation for unrelated and matched sibling donor transplants in acquired severe aplastic anemia: a study from the British Society for Blood and Marrow Transplantation.
Marsh JC; Pearce RM; Koh MB; Lim Z; Pagliuca A; Mufti GJ; Perry J; Snowden JA; Vora AJ; Wynn RT; Russell N; Gibson B; Gilleece M; Milligan D; Veys P; Samarasinghe S; McMullin M; Kirkland K; Cook G;
Bone Marrow Transplant; 2014 Jan; 49(1):42-8. PubMed ID: 23912664
[TBL] [Abstract][Full Text] [Related]
17. First-line treatment for severe aplastic anemia in children: bone marrow transplantation from a matched family donor versus immunosuppressive therapy.
Yoshida N; Kobayashi R; Yabe H; Kosaka Y; Yagasaki H; Watanabe K; Kudo K; Morimoto A; Ohga S; Muramatsu H; Takahashi Y; Kato K; Suzuki R; Ohara A; Kojima S
Haematologica; 2014 Dec; 99(12):1784-91. PubMed ID: 25193958
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow transplantation for severe aplastic anemia: a randomized controlled study of conditioning regimens.
Champlin RE; Perez WS; Passweg JR; Klein JP; Camitta BM; Gluckman E; Bredeson CN; Eapen M; Horowitz MM
Blood; 2007 May; 109(10):4582-5. PubMed ID: 17272503
[TBL] [Abstract][Full Text] [Related]
19. Impact of T-cell depletion strategies on outcomes following hematopoietic stem cell transplantation for idiopathic aplastic anemia: A study on behalf of the European blood and marrow transplant severe aplastic anemia working party.
Samarasinghe S; Clesham K; Iacobelli S; Sbianchi G; Knol C; Hamladji RM; Socié G; Aljurf M; Koh M; Sengeloev H; Dalle JH; Robinson S; Van Lint MT; Halkes CJM; Beelen D; Mufti GJ; Snowden J; Blaise D; de Latour RP; Marsh J; Dufour C; Risitano AM;
Am J Hematol; 2019 Jan; 94(1):80-86. PubMed ID: 30328134
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of severe aplastic anemia with bone marrow transplants or with antithymocyte globulin. Evaluation of 27 patients].
Arranz R; Steegmann JL; Fernández-Garesse D; Figuera A; Vázquez L; Fernández-Rañada JM
Rev Clin Esp; 1989 Feb; 184(3):121-4. PubMed ID: 2655043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
